109 related articles for article (PubMed ID: 16565509)
1. Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.
Arendt LM; Rose-Hellekant TA; Sandgren EP; Schuler LA
Am J Pathol; 2006 Apr; 168(4):1365-74. PubMed ID: 16565509
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc.
Kundel DW; Stromquist E; Greene AL; Zhdankin O; Regal RR; Rose-Hellekant TA
Transgenic Res; 2012 Apr; 21(2):393-406. PubMed ID: 21863248
[TBL] [Abstract][Full Text] [Related]
3. ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.
Morato A; Accornero P; Hovey RC
J Mammary Gland Biol Neoplasia; 2023 May; 28(1):10. PubMed ID: 37219601
[TBL] [Abstract][Full Text] [Related]
4. Prolactin: The Third Hormone in Breast Cancer.
Schuler LA; O'Leary KA
Front Endocrinol (Lausanne); 2022; 13():910978. PubMed ID: 35784527
[TBL] [Abstract][Full Text] [Related]
5. A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation.
Campbell KM; O'Leary KA; Rugowski DE; Mulligan WA; Barnell EK; Skidmore ZL; Krysiak K; Griffith M; Schuler LA; Griffith OL
Cell Rep; 2019 Aug; 28(6):1526-1537.e4. PubMed ID: 31390566
[TBL] [Abstract][Full Text] [Related]
6. Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.
Volker SE; Hedrick SE; Feeney YB; Clevenger CV
Cancer Res; 2018 Jul; 78(14):3877-3887. PubMed ID: 29959151
[TBL] [Abstract][Full Text] [Related]
7. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.
Farooqui M; Bohrer LR; Brady NJ; Chuntova P; Kemp SE; Wardwell CT; Nelson AC; Schwertfeger KL
Mol Cancer; 2015 Jul; 14():138. PubMed ID: 26215578
[TBL] [Abstract][Full Text] [Related]
8. Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.
O'Leary KA; Shea MP; Schuler LA
Adv Exp Med Biol; 2015; 846():201-20. PubMed ID: 25472540
[TBL] [Abstract][Full Text] [Related]
9. Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo.
O'Leary KA; Jallow F; Rugowski DE; Sullivan R; Sinkevicius KW; Greene GL; Schuler LA
Endocrinology; 2013 Dec; 154(12):4483-92. PubMed ID: 24064365
[TBL] [Abstract][Full Text] [Related]
10. Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
J Biol Chem; 2013 May; 288(18):12722-32. PubMed ID: 23530035
[TBL] [Abstract][Full Text] [Related]
11. Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.
Muthuswamy SK
Genes Dev; 2012 Oct; 26(20):2253-8. PubMed ID: 23070811
[TBL] [Abstract][Full Text] [Related]
12. Prolactin promotes mammary pathogenesis independently from cyclin D1.
Asher JM; O'Leary KA; Rugowski DE; Arendt LM; Schuler LA
Am J Pathol; 2012 Jul; 181(1):294-302. PubMed ID: 22658484
[TBL] [Abstract][Full Text] [Related]
13. Mouse models of estrogen receptor-positive breast cancer.
Mohibi S; Mirza S; Band H; Band V
J Carcinog; 2011; 10():35. PubMed ID: 22279420
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
15. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
16. Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
Carver KC; Piazza TM; Schuler LA
J Biol Chem; 2010 Mar; 285(11):8003-12. PubMed ID: 20080972
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.
Arendt LM; Evans LC; Rugowski DE; Garcia-Barchino MJ; Rui H; Schuler LA
J Endocrinol; 2009 Oct; 203(1):99-110. PubMed ID: 19635758
[TBL] [Abstract][Full Text] [Related]
18. Complex prolactin crosstalk in breast cancer: new therapeutic implications.
Carver KC; Arendt LM; Schuler LA
Mol Cell Endocrinol; 2009 Aug; 307(1-2):1-7. PubMed ID: 19524120
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.
Arendt LM; Grafwallner-Huseth TL; Schuler LA
Am J Pathol; 2009 Mar; 174(3):1065-74. PubMed ID: 19179608
[TBL] [Abstract][Full Text] [Related]
20. SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.
Piazza TM; Lu JC; Carver KC; Schuler LA
Mol Endocrinol; 2009 Feb; 23(2):202-12. PubMed ID: 19056863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]